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TFIIB is an RNA polymerase II general transcription Results and discussion
factor (GTF) that has also been implicated in the We used a previously described screen designed to isolate
mechanism of action of certain promoter-specific TBP mutants defective for transcription activation [15]
activators (see, for examples, [1–11]). TFIIB enters from a library in which the three TBP residues that medi-
the preinitiation complex (PIC) primarily through ate interaction with TFIIB (E186, E188, and L189) were
contact with the TATA box binding protein (TBP), randomly mutagenized in the context of an altered-speci-
an interaction mediated by three TBP residues ficity TBP derivative, TBPm3 [16] (see the Supplemen-
[12–14]. To study the role of TFIIB in transcription tary material available with this article online). From this
activation in vivo, we randomly mutagenized these screen, we recovered four substitution mutants: E186D,
three residues in yeast TBP and screened for E186K, E186S, and L189S. To test whether these new
promoter-specific activation mutants. One mutant TBPmutants could support viability, we introduced them
bearing a single conservative substitution, TBP- in the context of wild-typeTBP rather than in the altered-
E186D, is the focus of this study. As expected, TBP- specificity background. Figure 1a shows that strains con-
E186D binds normally to the TATA box but fails to taining either E186D or L189S as the sole source of TBP
support the entry of TFIIB into the PIC. Cells supported cell growth, whereas strains containing E186K
expressing TBP-E186D are viable but have a severe and E186S could not. Consistent with these results, previ-
slow-growth phenotype. Whole-genome expression ous studies have shown that neither TBP-E186A nor
analysis indicates that transcription of 17% of yeast TBP-E186R could support cell growth ([17] and our un-
genes are compromised by this mutation. Chimeric published data). Although viable, cells expressing E186D
promoter analysis indicates that the region of the or L189S had a slow-growth phenotype (Figure 1b). The
gene that confers sensitivity to the TBP-E186D growth phenotype of TBP-E186D, the focus of this study,
mutation is the UAS (upstream activating was very similar to that of N2-1, a TBP mutant defective
sequence), which contains the activator binding for interaction with TFIIA [18]. TBP-F148L, a represen-
sites. Most interestingly, other TBP mutants that tative example of a class of mutants with substitutions on
interfere with different interactions (TFIIB, TFIIA, or the TBPDNA binding surface [15], grew at the wild-type
the TATA box) and a TFIIB mutant defective for rate. To determine whether the slow-growth phenotype
interaction with TBP all manifest distinct and resulted from decreased TBP expression, immunoblot
selective promoter-specific activation defects. Our analysis was performed. Figure 1c shows that the level
results implicate the entry of TFIIB into the PIC as of TBP in cells expressing wild-type TBP, TBP-F148L,
a critical step in the activation of certain promoters TBP-L189S, TBP-E186D, and TBP-N2-1 was compa-
and reveal diverse mechanisms of transcription rable.
activation.
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It seemed likely that the slow-growth phenotype of TBP-
0960-9822/01/$ – see front matter E186Dwas due to decreased expression of genes required
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for optimal growth rates. To test this possibility, we per-
formed genome-wide expression analysis using high-den-
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Figure 1
Isolation and characterization of a novel TBP mutant. (a) Growth of immunoblotting using a polyclonal -TBP antibody. (d) Mobility shift
yeast strains expressing WT, F148L, L189S, E186D, E186S, or assays. (Top) Increasing amounts of his-tagged WT, L189S, or
E186K on a 5-FOA plate at 30C in a plasmid shuffle assay. (b) E186D were incubated with a 32P-labeled DNA fragment containing
Growth of yeast strains expressing WT, F148L, L189S, E186D, or the adenovirus 2 major late promoter (AdMLP) TATA box. (Bottom)
N2-1 in YPD liquid medium at 30C. (c) Immunoblot analysis. Whole- Increasing amounts of his-tagged WT, L189S, or E186D were
cell extracts were prepared from strains expressing WT, F148L, incubated with a 32P-labeled AdMLP TATA box in the presence of
L189S, E186D, or N2-1, and the level of TBP was determined by his-tagged yeast TFIIB.
sity DNA oligonucleotide arrays [19]. Transcription of whereas transcription of PHO11 was significantly lower
than in wild-type cells. Finally, PHO11 was the only gene5382 genes was analyzed in cells expressing TBP-E186D
or an isogenic wild-type strain in two independent experi- affected by the DNA binding surface mutants, F148L
and L189S. Thus, these four genes displayed strikinglyments. Of 5382 genes analyzed, transcription of 911 genes
was decreased 2-fold or greater in cells expressing TBP- variable sensitivities to mutations in different TBP inter-
faces.E186D. Thus, transcription of approximately 17% of yeast
genes is compromised by the TBP-E186D mutation. In
addition, transcription of 177 genes (3.3%) was increased We next tested the effects of TBP-E186D on five well-
2-fold or greater. characterized transcriptionally inducible genes: GAL1,
CUP1, SSA4 (HSP70), INO1, and HIS3. Figure 2b shows
that, in cells expressing TBP-E186D, transcriptional in-To examine a subset of the genes that, based upon the
genome-wide expression analysis, were significantly af- duction of GAL1 was severely impaired. A similar result
was obtained following ectopic expression of Gal4p [20],fected by the TBP-E186D mutation, we performed S1
nuclease protection analysis (Figure 2a). For comparison, indicating that the lack of GAL1 induction was not due
to suboptimal expression of Gal4p. Significantly, however,transcription of these same genes in cells expressing three
other TBP interface mutants, TBP-N2-1, TBP-L189S, transcriptional induction of CUP1, SSA4, INO1, and HIS3
was unaffected by TBP-E186D. Thus, these induciblyandTBP-F184L,was analyzed in parallel. Consistentwith
the genome-wide expression analysis, in cells expressing expressed genes also displayed differential sensitivity to
theTBP-E186Dmutation. TheTBPDNAbinding surfaceTBP-E186D, transcription of all four genes (CHA1, CLN2,
CYC1, and PHO11) was significantly compromised. Inter- mutants, TBP-F148L and TBP-L189S, supported wild-
type levels of CUP1, SSA4, INO1, and HIS3 transcriptionestingly, in cells expressing TBP-N2-1, transcription of
CHA1, CLN2, and CYC1 was relatively unaffected, and were modestly compromised for GAL1 transcription.
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Figure 2 E186D mutation, whereas ENO2UAS-CHA1CORE was not.
In the second case, we chose GAL1 (E186D sensitive)
and CUP1 (E186D insensitive). Figure 3b shows that
CUP1UAS-GAL1CORE was transcriptionally induced to high
levels, whereas transcription of the reciprocal chimera,
GAL1UAS-CUP1CORE, was severely compromised by the
TBP-E186D mutation. Based upon these combined re-
sults, we conclude that the UAS, which contains the acti-
vator binding sites, confers sensitivity to the TBP-E186D
mutation.
Our results show thatmutation in theTBP-TFIIB interface
affects a subset of genes and that the UAS, which contains
the activator binding sites, confers sensitivity to the TBP-
E186D mutation. A yeast TFIIB mutant, TFIIB-S53P,
exhibits promoter-specific activation defects resulting, at
least in part, from a failure to interact with certain activa-
tion domains [10]. To examine the relationship between
genes affected by TBP-E186D and TFIIB-S53P, we per-
formed genome-wide expression analysis using high-den-
sity DNA oligonucleotide arrays on a yeast strain express-
ing TFIIB-S53P. Of 6559 genes tested, transcription of
approximately 9% was decreased 2-fold or greater. Inter-
estingly, several of the most affected genes are involved
in the pheromone response pathway. Figure 4a shows
that, following the addition of  mating factor, transcrip-
tional activation of BAR1, FUS3, MFA, and SST2 was
severely impaired in a strain expressing TFIIB-S53P. In
contrast, in a strain expressing TBP-E186D, transcriptional
activation of these genes was comparable to wild-type.
We next compared the data from genome-wide expression
analysis between TBP-E186D and TFIIB-S53P. Signifi-
cantly, transcription of only a small number of genes was
impaired in both mutants (5% of the genes affected by
the TFIIB-S53P mutation). Of those genes affected by
Differential effects of TBP interface mutants on transcription. (a) both mutants, several are involved in the phosphate-star-
Transcription of CHA1, CLN2, CYC1, or PHO11 was quantitated vation pathway. As shown in Figure 4b, induction ofPHO5by S1 nuclease protection in strains expressing the indicated TBP
and PHO11 were severely impaired by TBP-E186D asmutant (top). Transcription of DED1 and ENO2 was quantitated by
S1 nuclease protection and was used as a normalization control. (b) well as TFIIB-S53P. Transcription of inducible genes was
Transcription of GAL1, CUP1, SSA4 (HSP70), INO1, or HIS3 was not generally affected; for example, activation of GAL1 in
quantitated by S1 nuclease protection in strains expressing the wild-type cells and a strain expressing TFIIB-S53P was
indicated TBP mutant (top). Transcription of DED1 was quantitated
comparable (Figure 4c).by S1 nuclease protection and was used as a normalization control.
Here, we isolate and characterize a new TBP mutant
compromised for interaction with TFIIB and exhibiting a
series of promoter-specific activation defects. Previously,The promoter-specific requirement for various transcrip-
tional components has been mapped either to the UAS Lee and Struhl [17] analyzed several yeast TBP mutants
compromised for interaction with TFIIB and found that(upstream activating sequence) or to the core promoter
(see, for examples, [21, 22]). To determine whether the a small number of genes tested were transcribed normally.
There are several significant differences between ourUAS or the core promoter confers sensitivity to the TBP-
E186D mutation, we constructed chimeras using promot- study and that of Lee and Struhl (1997), which likely
accounts for their failure to observe activation defects.ers that were either sensitive or insensitive to the TBP-
E186D mutation. In one case, we chose CHA1 (E186D First, Lee and Struhl [17] analyzed several directed TBP
mutations, whereas we randomly mutated the three resi-sensitive) and ENO2 (E186D insensitive). As shown in
Figure 3a, CHA1UAS-ENO2CORE was sensitive to the TBP- dues that mediate interaction with TFIIB and screened
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Figure 3
The UAS confers sensitivity to TBP-E186D. (a) Transcription of Transcription of chimeric promoters, GAL1UAS-CUP1corepromoter-LacZ
chimeric promoters, CHA1UAS-ENO2corepromoter-LacZ and and CUP1UAS-GAL1corepromoter-LacZ, in strains expressing wild-
ENO2UAS-CHA1corepromoter-LacZ, in strains expressing wild-type TBP type TBP or TBP-E186D was measured by a -galactosidase activity
or TBP-E186D was measured by -galactosidase activity. (b) assay and was plotted as fold induction.
for activation-defective mutants. Second, Lee and Struhl growth, and even this substitution resulted in a slow-growth
phenotype. If more severe mutations at TBP-E186 could[17] monitored only a few genes, whereas we performed
genome-wide expression analysis. Finally, we note that be analyzed in a comparable fashion, it seems likely that
they would have a more general transcriptional defect.our findings are supported by the isolation of human
TFIIB mutants that interfere with the TBP-TFIIB inter-
action and are differentially responsive to activators [23]. It has been suggested that sensitivity to mutations that
disrupt a specific protein-protein or protein-DNA interac-
tion can reveal the rate-limiting step(s) in PIC assemblySignificantly, both our study and that of Lee and Struhl
[17] found that most TBPmutants defective for interaction [15, 17, 18]. If this supposition is correct, our results indi-
cate that the TBP-TFIIB interaction is rate limiting atwithTFIIB failed to support cell growth, reflecting a severe
transcriptional impairment of some genes. In fact, at TBP- certain promoters. However, we believe that this experi-
mental approach is not sufficient to draw a rigorous conclu-E186, only a conservative substitution supported cell
Figure 4
Differential transcriptional effects of TBP-E186D and TFIIB-S53P. (a) was quantitated by S1 nuclease protection and was used as a
Transcription of pheromone response genes. Transcription was normalization control. (b) Transcription of genes involved in
quantitated by S1 nuclease protection. Transcription of a tRNA gene phosphate utilization. (c) GAL1 transcription.
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